A clinical trial recently showed that nearly half of individuals with type 2 diabetes achieved remission to a non-diabetic state after a weight-loss intervention delivered within 6 years of diagnosis. Now a study published August 2nd in the journal Cell Metabolism reveals that this successful response to weight loss is associated with the early and sustained improvement in the functioning of pancreatic beta cells. This finding challenges the previous paradigm that beta-cell function is irreversibly lost in patients with type 2 diabetes.
Roy Taylor, Ahmad Al-Mrabeh, Sviatlana Zhyzhneuskaya, Carl Peters, Alison C. Barnes, Benjamin S. Aribisala, Kieren G. Hollingsworth, John C. Mathers, Naveed Sattar, Michael E.J. Lean. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. Cell Metabolism, 2018; DOI: 10.1016/j.cmet.2018.07.003
Source: Science Daily
(Score: 2) by linkdude64 on Saturday August 04 2018, @02:46AM (1 child)
PHARMACEUTICAL INDUSTRY LIES TO ITS PATIENTS TO KEEP THEM COMPLACENT AND RELIANT ON MEDICATION!
(Score: 1, Funny) by Anonymous Coward on Saturday August 04 2018, @03:12AM
Butbut, muh series of contracts!